Terms: = Head and neck cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2
838 results:
1. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal cancer.
Muniz IAF; Araujo M; Bouassaly J; Farshadi F; Atique M; Esfahani K; Bonan PRF; Hier M; Mascarella M; Mlynarek A; Alaoui-Jamali M; Silva SDD
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612819
[TBL] [Abstract] [Full Text] [Related]
2. [Stratified application of gene expression in diagnosis of thyroid nodules].
Guan WY; Zheng JY; Nie L; Wu HY
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):264-268. PubMed ID: 38433054
[No Abstract] [Full Text] [Related]
3. An atlas of epithelial cell states and plasticity in lung adenocarcinoma.
Han G; Sinjab A; Rahal Z; Lynch AM; Treekitkarnmongkol W; Liu Y; Serrano AG; Feng J; Liang K; Khan K; Lu W; Hernandez SD; Liu Y; Cao X; Dai E; Pei G; Hu J; Abaya C; Gomez-Bolanos LI; Peng F; Chen M; Parra ER; Cascone T; Sepesi B; Moghaddam SJ; Scheet P; Negrao MV; Heymach JV; Li M; Dubinett SM; Stevenson CS; Spira AE; Fujimoto J; Solis LM; Wistuba II; Chen J; Wang L; Kadara H
Nature; 2024 Mar; 627(8004):656-663. PubMed ID: 38418883
[TBL] [Abstract] [Full Text] [Related]
4.
Sfreddo HJ; Koh ES; Zhao K; Swartzwelder CE; Untch BR; Marti JL; Roman BR; Dublin J; Wang RS; Xia R; Cohen JM; Xu B; Ghossein R; Givi B; Boyle JO; Tuttle RM; Fagin JA; Wong RJ; Morris LGT
Thyroid; 2024 Apr; 34(4):450-459. PubMed ID: 38407967
[No Abstract] [Full Text] [Related]
5. CDKN2A-p16 Deletion and Activated kras
Sun J; Sepulveda JL; Komissarova EV; Hills C; Seckar TD; LeFevre NM; Simonyan H; Young C; Su G; Del Portillo A; Wang TC; Sepulveda AR
Cell Mol Gastroenterol Hepatol; 2024; 17(5):769-784. PubMed ID: 38296052
[TBL] [Abstract] [Full Text] [Related]
6. A Comprehensive Approach to the Thyroid Bethesda Category III (AUS) in the Transition Zone Between 2nd Edition and 3rd Edition of The Bethesda System for Reporting Thyroid Cytopathology: Subcategorization, Nuclear Scoring, and More.
Bagıs M; Can N; Sut N; Tastekin E; Erdogan EG; Bulbul BY; Sezer YA; Kula O; Demirtas EM; Usta I
Endocr Pathol; 2024 Mar; 35(1):51-76. PubMed ID: 38280141
[TBL] [Abstract] [Full Text] [Related]
7. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
8. Liprin-α1 contributes to oncogenic MAPK signaling by counteracting ERK activity.
Pehkonen H; Filippou A; Väänänen J; Lindfors I; Vänttinen M; Ianevski P; Mäkelä A; Munne P; Klefström J; Toppila-Salmi S; Grénman R; Hagström J; Mäkitie AA; Karhemo PR; Monni O
Mol Oncol; 2024 Mar; 18(3):662-676. PubMed ID: 38264964
[TBL] [Abstract] [Full Text] [Related]
9. Global research on sinonasal inverted papilloma over the past two decades: a bibliometric analysis.
Fan D; Zhu Y; Yang J; Hou J
Acta Otorhinolaryngol Ital; 2024 Apr; 44(2):83-90. PubMed ID: 38165205
[TBL] [Abstract] [Full Text] [Related]
10. Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy.
Miraki Feriz A; Bahraini F; Khosrojerdi A; Azarkar S; Sajjadi SM; HosseiniGol E; Honardoost MA; Saghafi S; Silvestris N; Leone P; Safarpour H; Racanelli V
PLoS One; 2023; 18(12):e0295863. PubMed ID: 38096229
[TBL] [Abstract] [Full Text] [Related]
11. Brusatol attenuated proliferation and invasion induced by kras in differentiated thyroid cancer through inhibiting Nrf2.
Gong Z; Xue L; Vlantis AC; van Hasselt CA; Chan JYK; Fang J; Wang R; Yang Y; Li D; Zeng X; Tong MCF; Chen GG
J Endocrinol Invest; 2024 May; 47(5):1271-1280. PubMed ID: 38062319
[TBL] [Abstract] [Full Text] [Related]
12. Decoding the role of miRNAs in oral cancer pathogenesis: A focus on signaling pathways.
Doghish AS; El-Husseiny AA; Khidr EG; Elrebehy MA; Elballal MS; Abdel-Reheim MA; Abdel Mageed SS; Zaki MB; Mohammed OA; Khaled R; El-Dakroury WA; Noureldin S; Moustafa YM; Mangoura SA; Gedawy EM; Abulsoud AI
Pathol Res Pract; 2023 Dec; 252():154949. PubMed ID: 37992507
[TBL] [Abstract] [Full Text] [Related]
13. Gene mutations as predictors of central lymph mode metastasis in cN0 PTC: A meta-analysis.
Ji J; Shi X
Clin Genet; 2024 Feb; 105(2):130-139. PubMed ID: 37985961
[TBL] [Abstract] [Full Text] [Related]
14. Fine-needle biopsy of thyroid nodules and the contribution of molecular analysis of BRAF and RAS mutations.
Kasko M; Grigerova M; Alemayehu A; Zavodna K; Kasko V; Podoba J
Bratisl Lek Listy; 2023; 124(12):869-872. PubMed ID: 37983279
[TBL] [Abstract] [Full Text] [Related]
15. Sialadenoma papilliferum-like intraductal papillary tumour: an emerging entity with intercalated duct differentiation showing MAPK pathway activation in both ductal and myoepithelial cells.
Oh KY; Kim JH; Hong SD; Yoon HJ
Pathology; 2024 Feb; 56(1):52-58. PubMed ID: 37973455
[TBL] [Abstract] [Full Text] [Related]
16. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks.
Tokizaki S; Podyma-Inoue KA; Matsumoto T; Takahashi K; Kobayashi M; Ibi H; Uchida S; Iwabuchi S; Harada H; Hashimoto S; Miyazono K; Shirouzu M; Watabe T
Cancer Sci; 2024 Jan; 115(1):211-226. PubMed ID: 37972575
[TBL] [Abstract] [Full Text] [Related]
17. Effects of kras Genetic Interactions on Outcomes in cancers of the Lung, Pancreas, and Colorectum.
Grabski IN; Heymach JV; Kehl KL; Kopetz S; Lau KS; Riely GJ; Schrag D; Yaeger R; Irizarry RA; Haigis KM
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):158-169. PubMed ID: 37943166
[TBL] [Abstract] [Full Text] [Related]
18. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Pitfall in Thyroid Practice.
Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
[TBL] [Abstract] [Full Text] [Related]
19. Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification.
Zhou Y; Wu X; Zhang Y; Li Z; Ge X; Chen H; Mao Y; Ding W
PeerJ; 2023; 11():e16054. PubMed ID: 37744220
[TBL] [Abstract] [Full Text] [Related]
20. Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and HRAS Mutations: Report of a Case and Literature Review.
Hirose K; Shibahara T; Teramoto A; Usami Y; Ono S; Iwamoto Y; Murakami S; Oya K; Uzawa N; Motooka D; Hori Y; Morii E; Toyosawa S
Head Neck Pathol; 2023 Dec; 17(4):1026-1033. PubMed ID: 37735286
[TBL] [Abstract] [Full Text] [Related]
[Next]
